Yarrow Bioscience (YARW) Receivables - Net (2017 - 2023)
Yarrow Bioscience's (YARW) quarterly Receivables - Net came in at $250000.0 in Q3 2023, down 46.92% YoY from $471000.0 in Q3 2022, and up 6.84% on a QoQ basis from $234000.0 in Q2 2023.
Yarrow Bioscience (YARW) Receivables - Net (2017 - 2023) Analysis & Trends
Yarrow Bioscience (YARW) has 7 years of Receivables - Net data on file, last reported at $250000.0 in Q3 2023.
- Quarterly Receivables - Net fell 46.92% year-over-year to $250000.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $250000.0 (down 46.92% YoY) and the FY2022 annual result came in at $173000.0, down 97.72% from the prior year.
- Receivables - Net rose to $250000.0 in Q3 2023, from $234000.0 in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $15.8 million in Q4 2020 to a low of $105000.0 in Q1 2023.
- A 5-year average of $5.2 million and a median of $3.5 million in 2020 frame the typical range for Receivables - Net.
- Annual changes were most pronounced in 2020 — Receivables - Net jumped 11617.78% — and 2022, when it tumbled 97.72%.
- Tracing YARW's Receivables - Net over 5 years: stood at $135000.0 in 2019, then jumped by 11617.78% to $15.8 million in 2020, then slumped by 52.06% to $7.6 million in 2021, then plunged by 97.72% to $173000.0 in 2022, then jumped by 44.51% to $250000.0 in 2023.
- The last three Receivables - Net figures came in at $250000.0 (Q3 2023), $234000.0 (Q2 2023), and $105000.0 (Q1 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Yarrow Bioscience | 32.54 Mn | 9.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 250,000.00 |
| Sep 30, 2023 | 250,000.00 |
| Jun 30, 2023 | 234,000.00 |
| Jun 30, 2023 | 234,000.00 |
| Mar 31, 2023 | 105,000.00 |
| Mar 31, 2023 | 105,000.00 |
| Dec 31, 2022 | 173,000.00 |
| Dec 31, 2022 | 173,000.00 |
| Sep 30, 2022 | 471,000.00 |
| Sep 30, 2022 | 471,000.00 |
| Jun 30, 2022 | 304,000.00 |
| Jun 30, 2022 | 304,000.00 |
| Mar 31, 2022 | 535,000.00 |
| Mar 31, 2022 | 535,000.00 |
| Dec 31, 2021 | 7.58 Mn |
| Dec 31, 2021 | 7.58 Mn |
| Sep 30, 2021 | 10.08 Mn |
| Sep 30, 2021 | 10.08 Mn |
| Jun 30, 2021 | 10.87 Mn |
| Jun 30, 2021 | 10.87 Mn |